Ranibizumab is not bevacizumab for retinal vein occlusions

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 7, 2012, Pages 955-956

  Gallego Pinazo, Roberto ^a   Dolz Marco, Rosa ^a   Díaz Llopis, Manuel ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

BRANCH RETINAL VEIN OCCLUSION; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EPIRETINAL MEMBRANE; HEMORRHAGIC MACULAR INFARCTION; HUMAN; OFF LABEL DRUG USE; PRIORITY JOURNAL; REBOUND MACULAR EDEMA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA MACULOPATHY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; MACULAR EDEMA; RETINAL VEIN OCCLUSION;

EID: 84864289273     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2018-4     Document Type: Editorial

References (7)

1. Yilmaz T, Cordero-Coma M (2012) Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review. Graefes Arch Clin Exp Ophthalmol (in press)
2. Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG, Murahashi WY (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118(8):1594-1602
3. Meyer CH, Holz FG (2011) Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab. Eye (Lond) 25(6):661-672
4. Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA (2007) Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 27(4):426-431
5. Yasuda S, Kondo M, Kachi S, Ito Y, Terui T, Ueno S, Terasaki H (2011) Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 31(6):1075-1082
6. Marticorena J, Romano MR, Heimann H, Stappler T, Gibran K, Groenewald C, Pearce I, Wong D (2011) Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect? Br J Ophthalmol 95(3):391-395
7. Furino C, Boscia F, Cardascia N, Alessio G, Sborgia C (2010) Hemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. doi:10.3928/15428877-20100215-57